TAL1转录因子的异型在血液形成和细胞生长中具有不同的作用
Aveksha Sharma1, Shani Mistriel-Zerbib2, Rauf Ahmad Najar1
1Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
PLoS biology
|June 28, 2023
概括
这项研究揭示了TAL1蛋白质异型在血液细胞发育和T细胞急性淋巴细胞白血病 (T-ALL) 中的独特功能. TAL1-短异型可能会作为瘤抑制剂,这表明异型比率操纵是T-ALL.的治疗策略.
科学领域:
- 血液形成和癌症生物学
- 分子生物学和遗传学
背景情况:
- TAL1 (T细胞急性淋巴细胞白血病蛋白1) 是血液细胞发育中的关键转录因子.
- 过度表达TAL1是T-ALL,一种白血病的常见驱动因素.
- TAL1存在于两个异构体,短和长,由替代促进体和拼接产生的.
研究的目的:
- 研究TAL1短和长异型的不同作用和调控机制.
- 阐明增强剂和染色质结构如何影响TAL1异型表达和功能.
- 确定针对T-ALL.中的TAL1异型比率的治疗潜力.
主要方法:
- 通过操纵增强剂,绝缘剂和染色质可访问性来分析TAL1异型表达.
- 研究KMT2B在调节TAL1替代拼接中的作用.
- 评估TAL1异型与E蛋白合作伙伴的结合亲和力和转录活性.
- 评估TAL1异型表达在小鼠骨髓和K562细胞中的体内效应.
主要成果:
- 每个增强剂都特别促进TAL1促进剂的表达,从而产生独特的5' UTR和差异化转化控制.
- 增强剂通过KMT2B的介导,通过拼接部位的染色质修饰来调节TAL1外显子3的替代拼接.
- 与TAL1-long相比,TAL1-short对E蛋白伙伴具有更强的结合,并具有明显的亡转录特征.
- 在体内,单独TAL1-短表达就会导致造血干细胞枯竭,并促进红细胞形成,同时降低K562细胞的存活率.
结论:
- TAL1异形表达受到增强剂和染色质结构的严格调节,影响翻译和拼接.
- TAL1-short表现出独特的生物活动,包括瘤抑制功能,与TAL1-long不同.
- 准TAL1异型的比率为T细胞急性淋巴细胞白血病提供了一个新的治疗途径.
相关概念视频
Transcription Factors
76.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
76.2K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
General Transcription Factors
5.4K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.4K
Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K


